Reflecting on a great Biotech Outsourcing Strategies (BOS) event in Basel last week. We have seen interesting presentations of world leading Pharma and CDMOs with exceptional opportunities for networking and introducing NovoSere as CMC consulting company. Thank you to Bio2Business Ltd and the organizers for arranging this amazing event!
NovoSere’s Post
More Relevant Posts
-
Dr. BOBBY GEORGE is leading an engaging discussion at the 8th Annual Pharma Project and Portfolio Management 2025, examining how the Bio-Secure Act is influencing the pharma and biotech industries. The session is highlighting its impact on CDMOs, compliance, and global supply chains. #ebmpppm2025 #eminencegroupventures #eminencebusinessmedia #portfolio #projectmanagement
-
-
Dear Industry Colleagues, It's wonderful experience sharing knowledge at #CTSS on service portfolio of #ADVITY with Pharma and Biotech companies. Spectacular opportunity in exploring #BostonPharma and #BostonBiotech #Biopharma industry. #USPharma #USBiotech #USBiopharma #USGenerics
-
How sustainable is it for pharma companies to rely so heavily on a single product line? Novo Nordisk’s Wegovy and Ozempic now account for 17bn USD revenue or 61% of its total revenue of 29bn USD (2024 Q1-Q3). Eli Lilly and Company follows closely, with Mounjaro and Zepbound contributing 11bn USD or 35% of its total revenue revenues of 32bn USD (2024 Q1-Q3). #cphi #semaglutide #dcat QYOBO
-
Gesynta Pharma has been awarded a 𝗩𝗶𝗻𝗻𝗼𝘃𝗮 𝗴𝗿𝗮𝗻𝘁 to develop an environmentally friendly method for producing our drug candidate, 𝘃𝗶𝗽𝗼𝗴𝗹𝗮𝗻𝘀𝘁𝗮𝘁. Led by our project leader Maths Nilsson and carried out in collaboration with 𝗥𝗜𝗦𝗘, the project "𝙍𝙚𝙢𝙤𝙫𝙞𝙣𝙜 𝙘𝙝𝙡𝙤𝙧𝙞𝙣𝙖𝙩𝙚𝙙 𝙨𝙤𝙡𝙫𝙚𝙣𝙩𝙨 𝙛𝙧𝙤𝙢 𝙙𝙧𝙪𝙜 𝙘𝙖𝙣𝙙𝙞𝙙𝙖𝙩𝙚 𝙢𝙖𝙣𝙪𝙛𝙖𝙘𝙩𝙪𝙧𝙞𝙣𝙜 𝙥𝙧𝙤𝙘𝙚𝙨𝙨" demonstrates our commitment to pioneering innovative solutions in pharmaceutical manufacturing without compromising safety or quality. We're thrilled to contribute to sustainable development in the pharmaceutical industry together with Sweden's innovation agency Vinnova and Sweden's research institute and innovation partner RISE. Gesynta Pharma embraces and supports the UN Sustainable Development Goals (SDGs). Gesynta Pharma is dedicated to the development of better treatments for #endometriosis patients, with promising preclinical data for #vipoglanstat and a clinical phase II study coming. Vinnova RISE Research Institutes of Sweden ENDO1000 FEMaLe project #nonopioid #nonhormonal #drugdevelopment #esg #sustainabledevelopmentgoals #globalcompact
-
-
Excited to share news about our latest project to develop a more environmentally friendly manufacturing process for vipoglanstat. At Gesynta Pharma, we're proving that cutting-edge drug development and sustainability is a perfect match!
Gesynta Pharma has been awarded a 𝗩𝗶𝗻𝗻𝗼𝘃𝗮 𝗴𝗿𝗮𝗻𝘁 to develop an environmentally friendly method for producing our drug candidate, 𝘃𝗶𝗽𝗼𝗴𝗹𝗮𝗻𝘀𝘁𝗮𝘁. Led by our project leader Maths Nilsson and carried out in collaboration with 𝗥𝗜𝗦𝗘, the project "𝙍𝙚𝙢𝙤𝙫𝙞𝙣𝙜 𝙘𝙝𝙡𝙤𝙧𝙞𝙣𝙖𝙩𝙚𝙙 𝙨𝙤𝙡𝙫𝙚𝙣𝙩𝙨 𝙛𝙧𝙤𝙢 𝙙𝙧𝙪𝙜 𝙘𝙖𝙣𝙙𝙞𝙙𝙖𝙩𝙚 𝙢𝙖𝙣𝙪𝙛𝙖𝙘𝙩𝙪𝙧𝙞𝙣𝙜 𝙥𝙧𝙤𝙘𝙚𝙨𝙨" demonstrates our commitment to pioneering innovative solutions in pharmaceutical manufacturing without compromising safety or quality. We're thrilled to contribute to sustainable development in the pharmaceutical industry together with Sweden's innovation agency Vinnova and Sweden's research institute and innovation partner RISE. Gesynta Pharma embraces and supports the UN Sustainable Development Goals (SDGs). Gesynta Pharma is dedicated to the development of better treatments for #endometriosis patients, with promising preclinical data for #vipoglanstat and a clinical phase II study coming. Vinnova RISE Research Institutes of Sweden ENDO1000 FEMaLe project #nonopioid #nonhormonal #drugdevelopment #esg #sustainabledevelopmentgoals #globalcompact
-
-
Which are some of the biotechs making clinical leaps in Belgium? 🇧🇪 The land of chocolate, beer, and waffles, has a thriving biotech and life science sector, with more than 300 biopharmaceuticals operating in the country. 🧬 The country is positioned as Europe’s second-largest biotech industry, and has a number of life science clusters that specialize in a variety of fields. 💻💊🌿 Read our latest article to find out about some of the biotechs in Belgium that are climbing the ladder in the clinic. 👇 https://lnkd.in/d6zRcy7h #belgiumbiotech #biotechinnovation #lifesciencesector #clinicalresearch #biopharmaceuticals #lifescienceclusters #biotechindustry Agomab | Confo Therapeutics | Imcyse SA | Mithra | MRM Health | Precirix
-
-
📣 Encouraging Latinos in Bio members to attend this insightful workshop on mitigating risks in small molecule drug development! Join industry experts on February 6 at MassBio Hub for valuable discussions. Don’t miss out, register now! #Pharma #Biotech #LatinosInBio
Tedor Pharma Services, a Rhode Island-based CDMO, invites you to join our partners at a co-sponsored MassBio Hub event on February 6, 2025, from 4:30-7:30 PM. The topic: Mitigating Risk in Small Molecule Drug Development. This insightful workshop will explore key strategies for mitigating risks at every stage, from early-stage research to commercialization. Join our co-sponsors, The Solubility Company, Microsize and Corealis Pharma at the event to learn how our combined expertise can help you increase your drug product project's success. Ideal for: Pharma/Biotech companies and CMC consultants. The workshop is free and open to everyone, but space is limited so please use the link to register below. You do not have to be a MassBio member to attend the workshop. Register now: https://lnkd.in/e7YNeBmb Speakers include: TJ Higley , Mac., CEO of Microsize Yves Roy, President of Corealis Matthew Fodor, PhD, MBA, The Solubility Company Laura Iorio, MFA, CEO Tedor Pharma Services #TedorPharmaServices #Corealis #Microsize #TheSolubilityCompany #SmallMolecule #DrugDevelopment #Biotech #Pharma #RiskManagement #SmallMolecule #CDMO #MassBioHub #DrugDiscovery #RIBio Tedor Pharma Services; Corealis Pharma Inc.; Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development); The Solubility Company Here is a link to our websites for more information on the CDMO services provided: Tedor.com; CorealisPharma.com; Microsize.com; TheSolubilityCompany.com Tedor where innovators have it made!
-
-
Today we have announced our intention during 2025 to cease operations within Arecor’s subsidiary Tetris Pharma, and a mutual agreement with Xeris BioPharma Holdings, Inc to return Arecor’s rights to Ogluo® as part of our strategic focus on those areas which best leverage Arecor’s platform and resources to deliver transformational value opportunities. Sarah Howell, CEO, said: “This strategic decision consolidates Arecor’s focus on research and development in areas in which our innovative Arestat™ technology can deliver transformational opportunities. These include the progression of our next-generation insulin portfolio and innovation in the field of the oral delivery of peptides. We will also continue to progress our partnered portfolio of Arestat™ enabled superior therapeutics under our revenue generating technology licensing model. These present the greatest opportunities for the Group to build significant value and we remain confident in our strategy and excited about the opportunities for Arecor.” Read the full release here: https://lnkd.in/en2MS6NY #Arecor #Innovation #DrugDevelopment #Biotech
-
